BioSynth
BioSynth39About
What does BioSynth do?
BioSynth is a synthetic biology company focused on developing a platform for the sustainable production of materials. They leverage biological processes to create novel materials with reduced environmental impact, aiming to disrupt traditional manufacturing methods.
What is BioSynth's valuation?
StartupHub estimates BioSynth's effective valuation at $37.8M (range $25.0M to $60.0M, 10% confidence), based on comparable companies in the sector.
How much funding has BioSynth raised?
BioSynth has raised a total of $10M in funding. The most recent round on record is Seed.
Where is BioSynth headquartered?
BioSynth is headquartered in Cambridge, United Kingdom.
When was BioSynth founded?
BioSynth was founded in 2023.
What industry does BioSynth operate in?
BioSynth operates in Synthetic Biology, Sustainable Materials, Biotechnology, Advanced Manufacturing, Chemicals, Circular Economy.
No comments yet. Be the first to share your take.